About NGN Capital
NGN BioMed I, L.P. is a Venture Capital fund dedicated to Healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The Fund has flexibility to invest in a broad cross section of Healthcare and Biotechnology segments including drug products, medical devices and other healthcare segments like services. The fund is diversified by stage, from later stage to selected early stage opportunities, as well as by geography by investing predominantly in the US and in Europe.
NGN Capital Headquarter Location
369 Lexington Avenue
New York, New York, 10017-6524,
NGN Capital Team
8 Team Members
NGN Capital has 8 team members, including current President, Robert Ausman.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.